Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials

Title:	Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials
Authors:	Gossec, Laure^{Aff1, Aff2, Aff11, IDs13075025036700_cor1}; Balanescu, Andra^Aff3; D’Agostino, Maria Antonietta^{Aff4, Aff5}; Ogdie, Alexis^Aff6; Sewerin, Philipp^Aff7; Deng, Yu^Aff8; Shi, Linyu^Aff8; Sugimoto, Yoshiyuki^Aff9; Zhong, Sheng^Aff8; Xing, Yunzhao^Aff8; Lippe, Ralph^Aff8; Kishimoto, Mitsumasa^Aff10
Source:	Arthritis Research & Therapy. 28(1)
Database:	Springer Nature Journals